Scinovex
article Open AccessTop 1% cited

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

European Heart Journal · 2015 · Vol. 37(1) · pp. 67–119

Abstract

The ESC/ERS Guidelines represent the views of the ESC and ERS and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC and ERS are not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC/ERS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/ERS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC/ERS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC/ERS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

Pulmonary Hypertension Research and TreatmentsCardiovascular Function and Risk FactorsCongenital Heart Disease StudiesMedicineBosentanBalloonInternal medicineBMPR2Pulmonary hypertensionCardiologyAngioplastyBone morphogenetic protein receptorBrain natriuretic peptide

MeSH terms

AdultAlgorithmsAntihypertensive AgentsArrhythmias, CardiacChildCombined Modality TherapyConnective Tissue DiseasesCross InfectionDrug InteractionsEchocardiographyElectrocardiographyExercise TestExercise TherapyFemaleGenetic Counseling

Funding

  • European Respiratory Society
  • European Society of Cardiology
Citations
6,926
FWCI
474.73
field-weighted impact
References
484
Percentile
100%
vs. same field & year
Citations per year
References
Guidelines on the management of valvular heart disease (version 2012)
European Heart Journal · 2012 · 3,563 citations
Definitions and Diagnosis of Pulmonary Hypertension
Journal of the American College of Cardiology · 2013 · 1,747 citations
Clinical classification of pulmonary hypertension
Journal of the American College of Cardiology · 2004 · 1,898 citations
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
European Respiratory Journal · 2005 · 1,002 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.